Science as a tourist excursion: screening thousands of papers in Utrecht monuments – News

The consortium consists of 26 partners from ten European countries. It consists of experts from science, economics and politics. Four partners come from the Netherlands, namely Philips Medical System Nederland BV, Tilburg University, the Netherlands Cancer Institute and Utrecht University. The coordinating partner of the IMPROVE project is Universidad Politecnica de Madrid in Spain.

IMPROVE is a project supported by the Innovative Health Initiative Joint Undertaking (IHI JU) under grant agreement No. 101132847. The JU receives support from the European Union’s Horizon Europe research and innovation program and COCIR, EFPIA, EuropaBio, MedTech Europe , Vaccines Europe. The participating partners are Universidad Politecnica de Madrid (Spain), PredictBy (Spain), Danish Medicine Agency (Belgium), Roche (Switzerland), Institute for Economic Research (Slovenia), Copenhagen Institute for Futures Studies (Denmark), Fundació Institut d’ Investigació Biomèdica de Bellvitge (Spain), Philips Medical System Nederland BV (Netherlands), Heinrich-Heine-Universität Düsseldorf (Germany), Tilburg University (Netherlands), Dedalus (Italy), Fondazione Italiana Sclerosi Multipla Fism Onlus (Italy), AReSS Puglia (Italy), MultiMed (Italy), iserundschmidt GmbH (Germany), Better (Slovenia), The Netherlands Cancer Institute (Netherlands), St. Pölten University of Applied Sciences (Austria), Eye Hospital, University Medical Center Ljubljana (Slovenia), Utrecht University (Netherlands) , UDG Alliance (Switzerland), Medtronic Iberica SA (Spain), Fundacio Hospital Universitari Vall D’Hebron – Institut de Recerca (VHIR), Splosna Bolnisnica Celje (Slovenia), ORTOPEDSKA BOLNIŠNICA VALDOLTRA (Slovenia), ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS ( Greece).